ADELE CARUSO: Open Payments
NPI 1285673400 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 10 payments from 7 companies in 2025. Trend: 2023 $605 · 2024 $681 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $355 |
| AstraZeneca Pharmaceuticals LP | 2 | $232 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| UROGEN PHARMA, INC. | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $69 |
| PFIZER INC. | 1 | $57 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
Products named: Descovy, ONPATTRO, JELMYTO, FASENRA, Yeztugo, RYBREVANT, XTANDI, Natroba.
Industry payments across PA — which companies pay providers there.
